Navigation Links
MuGard Provides Significant Improvement or Stabilization of Oral Mucositis in Over 75% of Patients in European Clinical Experience
Date:10/11/2010

DALLAS and NEW YORK, Oct. 11 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP), a biopharmaceutical company specializing in products for cancer and supportive care, announced the highlights from a poster presentation on European clinical experience of MuGard at this year's European Society of Medical Oncology Conference in Milan, Italy.  Some of the findings reported in the ESMO presentation included:

  • MuGard provided a significant improvement and/or stabilization of oral mucositis lesions and symptoms of oral mucositis (OM) in more than 75% of cancer patients treated with radiotherapy/chemotherapy;
  • Patients reported a 52% significant reduction in oral discomfort (oral pain and swallowing ability) in patients with pre-existing lesions of OM, and reported a substantial reduction in the use of pain medication;
  • MuGard has a ready-to-use formulation that is well accepted by 86% of patients, as reported in this assessment program;
  • No MuGard-related adverse reactions have been identified in clinical practice;
  • MuGard represents a valuable therapeutic option in the treatment and prevention of OM in cancer patients undergoing radio/chemotherapy.

  • "These additional findings out of Europe are very exciting and strengthen our belief in the clinical benefits that MuGard can provide patients undergoing radiation and chemotherapy," said Jeffrey Davis, CEO of Access Pharmaceuticals.  He continued, "This data confirms the competitive advantages of MuGard over the current treatment options on the market and we will use this data to educate patients, clinicians and the medical industry on the superior attributes of our product."

    Earlier this year, Access presented MuGard data and clinical experience at the MASCC Conference (Multinational Association of Supportiv
    '/>"/>

    SOURCE Access Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
    2. Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)
    3. Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback
    4. Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America
    5. Access Pharmaceuticals Launches MuGard Product Website
    6. Access Pharmaceuticals, Inc. Signs $30M MuGard Supply Agreement With RHEI Pharmaceuticals HK LTD.
    7. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
    8. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    9. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
    10. Raptor Pharmaceuticals Provides Update of Product Programs
    11. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/4/2015)... TORONTO , May 4, 2015 ... that it intends to dividend to its stockholders a ... a definitive licensing agreement to license its RapidMist™ buccal ... (OTCQB:SMFI). As announced on April 23, 2015, ... respect of the licensing of its RapidMist™ buccal drug ...
    (Date:5/4/2015)... 4, 2015 Rogne Bioscience, a privately-held biotechnology ... that preclinical and mechanism of action data will be ... Investigative Dermatology (SID) Annual Meeting being held May 6-9, ... Georgia . Logo - http://photos.prnewswire.com/prnh/20150501/213318LOGO ... RON2315, a novel, low MW (<1700 daltons) peptide as ...
    (Date:5/4/2015)... 4, 2015   HeartWare International, Inc . (NASDAQ: ... support technologies that are revolutionizing the treatment of advanced heart ... , is scheduled to present at the Bank of America ... Vegas on Thursday, May 14, 2015, at 10:00 ... of the Company,s presentation at the conference will be available ...
    Breaking Medicine Technology:Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2
    ... Colo., May 13, 2011 Mesa Laboratories, Inc. (NASDAQ: ... of Directors has declared a regular quarterly cash dividend ... on June 15, 2011 to shareholders of record at ... Mesa Laboratories develops, acquires, manufactures and markets electronic ...
    ... Spine, a medical device company that designs, develops, manufactures ... disorders, today announced that the Company presented an overview ... the 6th Annual Spine Technology Summit, hosted by P&M ... California. "Life Spine has an extremely active ...
    Cached Medicine Technology:
    (Date:5/4/2015)... Johnson & Wales University (JWU) held a groundbreaking ceremony for ... Wednesday, April 22. , Johnson & Wales becomes the first ... re-alignment of Interstate-195. JWU’s new academic building, which will be ... Providence, is scheduled to be completed in July 2016. It ... purchased in 2012. , “It has long been our hope ...
    (Date:5/4/2015)... The Lymphoma Research Foundation (LRF) – ... innovative lymphoma research and serving the lymphoma community through ... patient services – is set to host its annual ... West Orange, NJ on June 1, 2015. Since 2010, ... programs through LRF. , This year, the Lymphoma Research ...
    (Date:5/4/2015)... 2015 Baptist Medical Center Jacksonville ... Get With The Guidelines®-Stroke Gold Plus Quality Achievement ... The award recognizes the hospital’s commitment and success ... appropriate treatment according to nationally recognized, research-based guidelines ... receive the Gold Plus Quality Achievement Award, hospitals ...
    (Date:5/4/2015)... Glendale, CA (PRWEB) May 04, 2015 ... intensify as baby boomers join the ranks of senior ... unprecedented demand on an already over-burdened healthcare system. Additionally, ... qualified staff to replace them. Per the U.S. Census ... is expected to increase 75% by 2050 while those ...
    (Date:5/4/2015)... 2015 EY today announced that Kevin ... finalist for the EY Entrepreneur Of The Year® 2015 ... program recognizes entrepreneurs who demonstrate excellence and extraordinary success ... commitment to their businesses and communities. Mr. MacDonald ... independent judges. Award winners will be announced on ...
    Breaking Medicine News(10 mins):Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2
    ... following is a,memorandum to editorial writers and columnists:, ... Communications,Director, SUBJECT: Katrina Storm Warning, On ... New Orleans,and the Gulf Coast are struggling to ... disasters in U.S. history. Disaster often strikes suddenly,and ...
    ... A new study released on,Monday, August 27, 2007 ... Prevention of Work-Related Musculoskeletal Disorders, held in,Boston, highlights ... both. Dr. Susan Buchanan, University of Illinois at,Chicago ... that raise,many questions as to why certain workers ...
    ... culprits behind the increase, , , THURSDAY, Aug. 30 (HealthDay ... sport early -- playing year-round, joining competitive club or ... believing they,ll put themselves on the fast track to ... , But for too many of these kids, that ...
    ... researchers say more study is needed to prove a link ... in damp, moldy homes may be prone to depression, a ... an analysis of mold and health conditions in several cities ... lead to the addition of emotional problems to the list ...
    ... The Mutter Museum will be taking its two Presidential ... the Arden Theater,s ASSASSINS on September 19., PHILADELPHIA, ... Arden Theater will display the actual remains of two,of ... opening,night of the Arden,s production of Assassins, Wednesday, September ...
    ... Calif., Aug. 30 Omnicell, Inc.,(Nasdaq: OMCL ) ... safety and operational efficiency in healthcare,facilities, today announced that ... vice president & CFO will present at the Thomas ... Boston, Mass.,on Wednesday, September 5, 2007 at 11:30 a.m. ...
    Cached Medicine News:Health News:Campaign for America's Future Memorandum: Katrina Storm Warning 2Health News:Campaign for America's Future Memorandum: Katrina Storm Warning 3Health News:Campaign for America's Future Memorandum: Katrina Storm Warning 4Health News:Campaign for America's Future Memorandum: Katrina Storm Warning 5Health News:New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites 2Health News:New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites 3Health News:More Kids Are Suffering Sports Injuries 2Health News:More Kids Are Suffering Sports Injuries 3Health News:Damp, Moldy Homes May Cause Depression 2Health News:Damp, Moldy Homes May Cause Depression 3Health News:Damp, Moldy Homes May Cause Depression 4Health News:The Mutter Assassins Go to the Theater! 2Health News:The Mutter Assassins Go to the Theater! 3Health News:Omnicell to Present at Thomas Weisel Healthcare Conference 2007 2
    The D-Stat Radial hemostat band utilizes a compression band together with the active haemostatic material of the D-Stat to control surface bleeding....
    ... added to the Perclose ... suture trimmer and numbered ... on the device. The ... knot advancement and suture ...
    The Prostar XL 8 is a suture mediated closure system. It can be used with 8F sheath. It has two 3-0 braided polyester sutures and also has the safety of guidewire....
    ... The Angio-Seal STS PLUS platform is composed ... specially designed absorbable polymer anchor connected by ... and sandwiches the arteriotomy between its two ... sponge. Hemostasis is achieved primarily through ...
    Medicine Products: